Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring2020Vol. 12(1), pp. e12095–e12095
Citations Over TimeTop 10% of 2020 papers
Hui‐Fu Wang, Xue‐Ning Shen, Jieqiong Li, John Suckling, Chen‐Chen Tan, Yan‐Jiang Wang, Lei Feng, Can Zhang, Lan Tan, Qiang Dong, Jacques Touchon, Serge Gauthier, Jin‐Tai Yu, Alzheimer's Disease Neuroimaging Initiative
Abstract
The trajectory in sporadic AD is led by Aβ accumulation, followed by CSF t-tau increase, memory deficits, brain atrophy, hypometabolism, and cognitive decline.
Related Papers
- → Temperature-Sensitive Paralytic Mutants Are Enriched For Those Causing Neurodegeneration in Drosophila(2002)93 cited
- → Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms(2018)45 cited
- → A Possible Neurodegeneration Mechanism Triggered by Diabetes(2019)32 cited
- Reactive oxygen species-mediated neurodegeneration is independent of the ryanodine receptor in Caernorhabditis elegans.(2015)
- → Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease(2017)3 cited